Exploring New Approaches for Human Cytomegalovirus Inhibition

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Virology".

Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 1131

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pediatrics, Division of Infectious Disease, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Interests: human cytomegalovirus; cytomegalovirus; infection; molecular virology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pediatrics, Division of Infectious Disease, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Interests: human cytomegalovirus; host-pathogen interaction; antiviral drug development

Special Issue Information

Dear Colleagues,

Human cytomegalovirus (HCMV) is a pervasive viral pathogen that poses significant health risks, particularly in immunocompromised individuals and neonates. Despite substantial progress in understanding HCMV biology and the development of antiviral therapies, challenges remain in effectively inhibiting HCMV infection, identyfying and managing drug resistance, and minimizing associated clinical complications. This Special Issue aims to explore new approaches for HCMV inhibition, presenting cutting-edge research and innovative strategies that hold promise in combatting this complex viral infection.

This Special Issue invites the submission of original research articles, reviews, and perspectives that encompass diverse aspects of HCMV inhibition, including, but not limited to:

  • Novel targets and mechanisms for inhibiting HCMV replication;
  • Development and evaluation of antiviral compounds and therapeutic agents against HCMV;
  • Combinatorial approaches and drug-repurposing strategies for HCMV inhibition;
  • Immunotherapeutic interventions and vaccine development for HCMV control;
  • Advancements in diagnostic methods and the monitoring of HCMV infection;
  • Insights into the mechanisms of HCMV drug resistance and management strategies;
  • Computational modeling and drug design approaches for HCMV inhibition;
  • Emerging technologies and platforms for the study of HCMV–host interactions.

We aim to foster collaboration, inspire new ideas, and advance our understanding of HCMV inhibition. We encourage researchers to submit their original work to this Special Issue, contributing to the development of effective therapeutic interventions, diagnostic tools, and preventive measures against HCMV.

Dr. Ravit Arav-Boger
Dr. Ayan Kumar Ghosh
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • human cytomegalovirus
  • antiviral
  • drug resistance

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop